Received Oct 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
developed a rash after getting Shingrix; This non-serious case was reported by a physician via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: developed a rash after getting Shingrix). The outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to Shingrix. It was unknown if the company considered the rash to be related to Shingrix. Additional Information: GSK Receipt Date: 06-OCT-2025 A Doctor of Medicine called to ask for information about the post-reactivity between Shingrix and the Varicella vaccine. The reporter stated that a patient had developed a rash after receiving Shingrix. The patient enquired whether she could receive the Varicella vaccine. The batch number was not provided upon follow- up with the reporter.